image
Nuvectis Pharma, Inc. NVCT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 10.205
-5.63 %
$ 213 M
Market Cap
-8.89
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
52.92%
Net Income Estimate
25.17%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Nuvectis Pharma, Inc.
image
NVCT has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart NVCT

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart NVCT

image
$70.0m$70.0m$60.0m$60.0m$50.0m$50.0m$40.0m$40.0m$30.0m$30.0m$20.0m$20.0m$10.0m$10.0m$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart NVCT

image
$10.0m$10.0m$5.0m$5.0m$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)20232023202420242025202520262026202720272028202820292029